TrialBlood advances2021

Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma.

Donald L Patrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.